Maternal and fetal lipid metabolism under normal and gestational diabetic conditions

Hormone Molecular Biology and Clinical Investigation

Volumn 26, Issue 2, 2016, Pages 109-127

  Herrera, Emilio ^a   Desoye, Gernot ^b  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

fatty acids; fetal lipids; gestational diabetes; human pregnancy; maternal lipids

Indexed keywords

ADIPOCYTOKINE; GLUCOSE; INSULIN; LIPID; LIPOPROTEIN; LONG CHAIN FATTY ACID; POLYUNSATURATED FATTY ACID; FATTY ACID; TRIACYLGLYCEROL;

ADIPOSE TISSUE; DYSLIPIDEMIA; FAT MASS; FATTY ACID OXIDATION; FEMALE; FETUS; FETUS (ANATOMY); FETUS CIRCULATION; FETUS DEVELOPMENT; FETUS GROWTH; HUMAN; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPID METABOLISM; LIPID STORAGE; LIPID TRANSPORT; NONHUMAN; OBESITY; PLACENTA; PLACENTAL TRANSFER; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; TISSUE METABOLISM; BLOOD; COMPLICATION; FETOMATERNAL TRANSFUSION; METABOLISM;

ADIPOSE TISSUE; DIABETES, GESTATIONAL; DYSLIPIDEMIAS; FATTY ACIDS, NONESTERIFIED; FEMALE; FETAL DEVELOPMENT; FETUS; HUMANS; LIPID METABOLISM; MATERNAL-FETAL EXCHANGE; PLACENTA; PREGNANCY; TRIGLYCERIDES;

EID: 85007403703     PISSN: 18681883     EISSN: 18681891     Source Type: Journal    
DOI: 10.1515/hmbci-2015-0025     Document Type: Review

References (223)

1. Balsells M, Garcia-Patterson A, Gich I, Corcoy R. Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and metaanalysis. J Clin Endocrinol Metab 2009;94:4284-91.
2. Melamed N, Hod M. Perinatal mortality in pregestational diabetes. Int J Gynaecol Obstet 2009;104:Suppl 1:S20-4.
3. Expert Committee on the D, Classification of Diabetes M. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26:Suppl 1:S5-20.
4. Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 1998;21:Suppl 2:B161-7.
5. American Diabetes A. Gestational diabetes mellitus. Diabetes Care 2004;27:Suppl 1:S88-90.
6. Spellacy WN, Miller S, Winegar A, Peterson PQ. Macrosomia-maternal characteristics and infant complications. Obstet Gynecol 1985;66:158-61.
7. Najafian M, Cheraghi M. Occurrence of fetal macrosomia rate and its maternal and neonatal complications: a 5-year cohort study. ISRN Obstet Gynecol 2012;2012:353791.
8. Pedersen J. Weight and length at birth of infants of diabetic mothers. Acta Endocrinol (Copenh) 1954;16:330-42.
9. Jimenez-Moleon JJ, Bueno-Cavanillas A, Luna-del-Castillo Jde D, Garcia-Martin M, Lardelli-Claret P, Galvez-Vargas R. Impact of different levels of carbohydrate intolerance on neonatal outcomes classically associated with gestational diabetes mellitus. Eur J Obstet Gynecol Reprod Biol 2002;102:36-41.
10. Sameshima H, Kamitomo M, Kajiya S, Kai M, Furukawa S, Ikenoue S. Early glycemic control reduces large-for-gestational-age infants in 250 Japanese gestational diabetes pregnancies. Am J Perinatol 2000;17:371-6.
11. Fraser D, Weitzman S, Leiberman JR, Eschwege E. Factors influencing birth weight in newborns of diabetic and nondiabetic women. A population based study. Eur J Epidemiol 1990;6:427-31.
12. Evers IM, de Valk HW, Mol BW, ter Braak EW, Visser GH. Macrosomia despite good glycaemic control in Type I diabetic pregnancy; results of a nationwide study in The Netherlands. Diabetologia 2002;45:1484-9.
13. Schwartz R, Gruppuso PA, Petzold K, Brambilla D, Hiilesmaa V, Teramo KA. Hyperinsulinemia and macrosomia in the fetus of the diabetic mother. Diabetes Care 1994;17:640-8.
14. Herrera E, Ortega-Senovilla H. Disturbances in lipid metabolism in diabetic pregnancy-Are these the cause of the problem? Best Pract Res Clin Endocrinol Metab 2010;24:515-25.
15. Schaefer-Graf UM, Graf K, Kulbacka I, Kjos SL, Dudenhausen J, Vetter K, Herrera E. Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabetes Care 2008;31:1858-63.
16. Schaefer-Graf UM, Meitzner K, Ortega-Senovilla H, Graf K, Vetter K, Abou-Dakn M, Herrera E. Differences in the implications of maternal lipids on fetal metabolism and growth between gestational diabetes mellitus and control pregnancies. Diabet Med 2011;28:1053-9.
17. Ortega-Senovilla H, Alvino G, Taricco E, Cetin I, Herrera E. Gestational diabetes mellitus upsets the proportion of fatty acids in umbilical arterial but not venous plasma. Diabetes Care 2009;32:120-2.
18. Hytten FE, Leitch I. The gross composition of the components of weight gain. In: Hytten FE, Leitch I, editors. The Physiology of Human Pregnancy, 2nd ed. Oxford: Blackwell, 1971:370-87.
19. Villar J, Cogswell M, Kestler E, Castillo P, Menendez R, Repke JT. Effect of fat and fat-free mass deposition during pregnancy on birth weight. Am J Obstet Gynecol 1992;167:1344-52.
20. Murphy SP, Abrams BF. Changes in energy intakes during pregnancy and lactation in a national sample of US women. Am J Public Health 1993;83:1161-3.
21. Andersen O, Kuhl C. Adipocyte insulin receptor binding and lipogenesis at term in normal pregnancy. Eur J Clin Invest 1988;18:575-81.
22. Ramos MP, Crespo-Solans MD, del Campo S, Cacho J, Herrera E. Fat accumulation in the rat during early pregnancy is modulated by enhanced insulin responsiveness. Am J Physiol Endocrinol Metab 2003;285:E318-28.
23. Alvarez JJ, Montelongo A, Iglesias A, Lasuncion MA, Herrera E. Longitudinal study on lipoprotein profile, high density lipoprotein subclass, and postheparin lipases during gestation in women. J Lipid Res 1996;37:299-308.
24. Rebuffe-Scrive M, Enk L, Crona N, Lonnroth P, Abrahamsson L, Smith U, Bjorntorp P. Fat cell metabolism in different regions in women. Effect of menstrual cycle, pregnancy, and lactation. J Clin Invest 1985;75:1973-6.
25. Mead JR, Irvine SA, Ramji DP. Lipoprotein lipase: structure, function, regulation, and role in disease. J Mol Med (Berl) 2002;80:753-69.
26. Lasuncion MA, Herrera E. "In Vitro" utilization of labelled esterified fatty acids and glyceride glycerol from triglyceride-rich lipoproteins in rat adipose tissue. Horm Metab Res 1981;13:335-9.
27. Lasuncion MA, Herrera E. Changes with starvation in the rat of the lipoprotein lipase activity and hydrolysis of triacylglycerols from triacylglycerol-rich lipoproteins in adipose tissue preparations. Biochem J 1983;210:639-43.
28. Williams C, Coltart TM. Adipose tissue metabolism in pregnancy: the lipolytic effect of human placental lactogen. Br J Obstet Gynaecol 1978;85:43-6.
29. Elliott JA. The effect of pregnancy on the control of lipolysis in fat cells isolated from human adipose tissue. Eur J Clin Invest 1975;5:159-63.
30. Dahlgren J. Pregnancy and insulin resistance. Metab Syndr Relat Disord 2006;4:149-52.
31. Barbour LA, McCurdy CE, Hernandez TL, Kirwan JP, Catalano PM, Friedman JE. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care 2007;30:Suppl 2:S112-9.
32. Sivan E, Homko CJ, Chen XH, Reece EA, Boden G. Effect of insulin on fat metabolism during and after normal pregnancy. Diabetes 1999;48:834-8.
33. Jaworski K, Sarkadi-Nagy E, Duncan RE, Ahmadian M, Sul HS. Regulation of triglyceride metabolism. IV. Hormonal regulation of lipolysis in adipose tissue. Am J Physiol Gastrointest Liver Physiol 2007;293:G1-4.
34. Langin D. Adipose tissue lipolysis revisited (again!): lactate involvement in insulin antilipolytic action. Cell metabolism 2010;11:242-3.
35. Lafontan M. Historical perspectives in fat cell biology: the fat cell as a model for the investigation of hormonal and metabolic pathways. Am J Physiol Cell Physiol 2012;302:C327-59.
36. Ryan EA, Enns L. Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab 1988;67:341-7.
37. Diderholm B, Stridsberg M, Ewald U, Lindeberg-Norden S, Gustafsson J. Increased lipolysis in non-obese pregnant women studied in the third trimester. BJOG 2005;112:713-8.
38. Boyadzhieva M, Atanasova I, Zacharieva S, Kedikova S. Adipocytokines during pregnancy and postpartum in women with gestational diabetes and healthy controls. J Endocrinol Invest 2013;36:944-9.
39. Wojcik M, Chmielewska-Kassassir M, Grzywnowicz K, Wozniak L, Cypryk K. The relationship between adipose tissue-derived hormones and gestational diabetes mellitus (GDM). Endokrynol Pol 2014;65:134-42.
40. Tessier DR, Ferraro ZM, Gruslin A. Role of leptin in pregnancy: consequences of maternal obesity. Placenta 2013;34:205-11.
41. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JE, Kalhan SC, Catalano PM. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 2002;51:2207-13.
42. Jahromi AS, Zareian P, Madani A. Association of Insulin Resistance with Serum Interleukin-6 and TNF-alpha Levels During Normal Pregnancy. Biomark Insights 2011;6:1-6.
43. Fasshauer M, Bluher M, Stumvoll M, Tonessen P, Faber R, Stepan H. Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function. Clin Endocrinol (Oxf) 2007;66:434-9.
44. Kasher-Meron M, Mazaki-Tovi S, Barhod E, Hemi R, Haas J, Gat I, Zilberberg E, Yinon Y, Karasik A, Kanety H. Chemerin concentrations in maternal and fetal compartments: implications for metabolic adaptations to normal human pregnancy. J Perinat Med 2014;42:371-8.
45. Ueland T, Dalsoren T, Voldner N, Godang K, Henriksen T, Bollerslev J. Retinol-binding protein-4 is not strongly associated with insulin sensitivity in normal pregnancies. Eur J Endocrinol 2008;159:49-54.
46. Nien JK, Mazaki-Tovi S, Romero R, Kusanovic JP, Erez O, Gotsch F, Pineles BL, Friel LA, Espinoza J, Goncalves L, Santolaya J, Gomez R, Hong JS, Edwin S, Soto E, Richani K, Mazor M, Hassan SS. Resistin: a hormone which induces insulin resistance is increased in normal pregnancy. J Perinat Med 2007;35:513-21.
47. Cseh K, Baranyi E, Melczer Z, Kaszas E, Palik E, Winkler G. Plasma adiponectin and pregnancy-induced insulin resistance. Diabetes Care 2004;27:274-5.
48. Skvarca A, Tomazic M, Blagus R, Krhin B, Janez A. Adiponectin/ leptin ratio and insulin resistance in pregnancy. J Int Med Res 2013;41:123-8.
49. Kourtis A, Gkiomisi A, Mouzaki M, Makedou K, Anastasilakis AD, Toulis KA, Gerou S, Gavana E, Agorastos T. Apelin levels in normal pregnancy. Clin Endocrinol (Oxf) 2011;75:367-71.
50. Desoye G, Hauguel-de Mouzon S. The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care 2007;30:Suppl 2:S120-6.
51. Sivan E, Homko CJ, Whittaker PG, Reece EA, Chen X, Boden G. Free fatty acids and insulin resistance during pregnancy. J Clin Endocrinol Metab 1998;83:2338-42.
52. Brun RP, Kim JB, Hu E, Spiegelman BM. Peroxisome proliferatoractivated receptor gamma and the control of adipogenesis. Curr Opin Lipidol 1997;8:212-8.
53. Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, Mortensen RM. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 1999;4:611-7.
54. Qiao L, Maclean PS, Schaack J, Orlicky DJ, Darimont C, Pagliassotti M, Friedman JE, Shao J. C/EBPalpha regulates human adiponectin gene transcription through an intronic enhancer. Diabetes 2005;54:1744-54.
55. Schoonjans K, Peinado-Onsurbe J, Lefebvre AM, Heyman RA, Briggs M, Deeb S, Staels B, Auwerx J. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J 1996;15:5336-48.
56. Rodriguez-Cuenca S, Carobbio S, Velagapudi VR, Barbarroja N, Moreno-Navarrete JM, Tinahones FJ, Fernandez-Real JM, Oresic M, Vidal-Puig A. Peroxisome proliferator-activated receptor gamma-dependent regulation of lipolytic nodes and metabolic flexibility. Mol Cell Biol 2012;32:1555-65.
57. Zeghari N, Vidal H, Younsi M, Ziegler O, Drouin P, Donner M. Adipocyte membrane phospholipids and PPAR-gamma expression in obese women: relationship to hyperinsulinemia. Am J Physiol Endocrinol Metab 2000;279:E736-E43.
58. Catalano PM, Nizielski SE, Shao J, Preston L, Qiao L, Friedman JE. Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: relationship to FFA during pregnancy. Am J Physiol Endocrinol Metab 2002;282:E522-33.
59. Montelongo A, Lasuncion MA, Pallardo LF, Herrera E. Longitudinal study of plasma lipoproteins and hormones during pregnancy in normal and diabetic women. Diabetes 1992;41:1651-9.
60. Jovanovic L, Metzger BE, Knopp RH,Conley MR, Park E, Lee YJ, Simpson JL, Holmes L, Aarons JH, Mills JL. The Diabetes in Early Pregnancy Study: beta-hydroxybutyrate levels in type 1 diabetic pregnancy compared with normal pregnancy. NICHD-Diabetes in Early Pregnancy Study Group (DIEP). National Institute of Child Health and Development. Diabetes Care 1998;21:1978-84.
61. Xu A, Wang Y, Xu JY, Stejskal D, Tam S, Zhang J, Wat NM, Wong WK, Lam KS. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem 2006;52:405-13.
62. Tso AW, Xu A, Sham PC, Wat NM, Wang Y, Fong CH, Cheung BM, Janus ED, Lam KS. Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care 2007;30:2667-72.
63. Yadav A, Kataria MA, Saini V, Yadav A. Role of leptin and adiponectin in insulin resistance. Clin Chim Acta 2013;417:80-4.
64. Gharibeh MY, Al Tawallbeh GM, Abboud MM, Radaideh A, Alhader AA, Khabour OF. Correlation of plasma resistin with obesity and insulin resistance in type 2 diabetic patients. Diabetes Metab 2010;36(6 Pt 1):443-9.
65. Tsiotra PC, Tsigos C, Anastasiou E, Yfanti E, Boutati E, Souvatzoglou E, Kyrou I, Raptis SA. Peripheral mononuclear cell resistin mRNA expression is increased in type 2 diabetic women. Mediators Inflamm 2008;2008:892864.
66. Norseen J, Hosooka T, Hammarstedt A, Yore MM, Kant S, Aryal P, Kiernan UA, Phillips DA, Maruyama H, Kraus BJ, Usheva A, Davis RJ, Smith U, Kahn BB. Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinaseand toll-like receptor 4-dependent and retinol-independent mechanism. Mol Cell Biol 2012;32:2010-9.
67. Ortega-Senovilla H, Schaefer-Graf U, Meitzner K, Abou-Dakn M, Graf K, Kintscher U, Herrera E. Gestational diabetes mellitus causes changes in the concentrations of adipocyte fatty acid-binding protein and other adipocytokines in cord blood. Diabetes Care 2011;34:2061-6.
68. Homko CJ, Sivan E, Reece EA, Boden G. Fuel metabolism during pregnancy. Semin Reprod Endocrinol 1999;17:119-25.
69. Knopp RH, Bonet B, Lasunción MA, Montelongo A, Herrera E. Lipoprotein metabolism in pregnancy. In: Herrera E, Knopp RH, editors. Perinatal Biochemistry. Boca Raton: CRC Press, 1992:19-51.
70. Wasfi I, Weinstein I, Heimberg M. Increased formation of triglyceride from oleate in perfused livers from pregnant rats. Endocrinology 1980;107:584-96.
71. Iglesias A, Montelongo A, Herrera E, Lasuncion MA. Changes in cholesteryl ester transfer protein activity during normal gestation and postpartum. Clin Biochem 1994;27:63-8.
72. Silliman K, Tall AR, Kretchmer N, Forte TM. Unusual highdensity lipoprotein subclass distribution during late pregnancy. Metabolism 1993;42:1592-9.
73. Kinnunen PK, Unnerus HA, Ranta T, Ehnholm C, Nikkila EA, Seppala M. Activities of post-heparin plasma lipoprotein lipase and hepatic lipase during pregnancy and lactation. Eur J Clin Invest 1980;10:469-74.
74. Brinton EA. Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate. Arterioscler Thromb Vasc Biol 1996;16:431-40.
75. Perret B, Mabile L, Martinez L, Terce F, Barbaras R, Collet X. Hepatic lipase: structure/function relationship, synthesis, and regulation. J Lipid Res 2002;43:1163-9.
76. Sanchez-Vera I, Bonet B, Viana M, Quintanar A, Martin MD, Blanco P, Donnay S, Albi M. Changes in plasma lipids and increased low-density lipoprotein susceptibility to oxidation in pregnancies complicated by gestational diabetes: consequences of obesity. Metabolism 2007;56:1527-33.
77. Hollingsworth DR, Grundy SM. Pregnancy-associated hypertriglyceridemia in normal and diabetic women. Differences in insulin-dependent, non-insulin-dependent, and gestational diabetes. Diabetes 1982;31:1092-7.
78. Koukkou E, Watts GF, Lowy C. Serum lipid, lipoprotein and apolipoprotein changes in gestational diabetes mellitus: a crosssectional and prospective study. J Clin Pathol 1996;49:634-7.
79. Marseille-Tremblay C, Ethier-Chiasson M, Forest JC, Giguere Y, Masse A, Mounier C, Lafond J. Impact of maternal circulating cholesterol and gestational diabetes mellitus on lipid metabolism in human term placenta. Mol Reprod Dev 2008;75:1054-62.
80. Rizzo M, Berneis K, Altinova AE, Toruner FB, Akturk M, Ayvaz G, Rini GB, Spinas GA, Arslan M. Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes. Diabet Med 2008;25:1406-11.
81. Qiu C, Rudra C, Austin MA, Williams MA. Association of gestational diabetes mellitus and low-density lipoprotein (LDL) particle size. Physiol Res 2007;56:571-8.
82. Jovanovic L, Peterson CM, Saxena BB, Dawood MY, Saudek CD. Feasibility of maintaining normal glucose profiles in insulindependent pregnant diabetic women. Am J Med 1980;68:105-12.
83. Thadhani R, Wolf M, Hsu-Blatman K, Sandler L, Nathan D, Ecker JL. First-trimester sex hormone binding globulin and subsequent gestational diabetes mellitus. Am J Obstet Gynecol 2003;189:171-6.
84. Cetin I, Parisi F, Berti C, Mando C, Desoye G. Placental fatty acid transport in maternal obesity. J Dev Orig Health Dis 2012;3:409-14.
85. Gil-Sanchez A, Koletzko B, Larque E. Current understanding of placental fatty acid transport. Curr Opin Clin Nutr Metab Care 2012;15:265-72.
86. Haggarty P. Fatty acid supply to the human fetus. Annu Rev Nutr 2010;30:237-55.
87. Duttaroy AK. Transport of fatty acids across the human placenta: a review. Prog Lipid Res 2009;48:52-61.
88. Cunningham P, McDermott L. Long chain PUFA transport in human term placenta. J Nutr 2009;139:636-9.
89. Winkel CA, MacDonald PC, Simpson ER. The role of receptormediated low-density lipoprotein uptake and degradation in the regulation of progesterone biosynthesis and cholesterol metabolism by human trophoblasts. Placenta Suppl 1981;3:133-43.
90. Winkel CA, Gilmore J, MacDonald PC, Simpson ER. Uptake and degradation of lipoproteins by human trophoblastic cells in primary culture. Endocrinology 1980;107:1892-8.
91. Gauster M, Hiden U, Blaschitz A, Frank S, Lang U, Alvino G, Cetin I, Desoye G, Wadsack C. Dysregulation of placental endothelial lipase and lipoprotein lipase in intrauterine growth-restricted pregnancies. J Clin Endocrinol Metab 2007;92:2256-63.
92. Gauster M, Hiden U, van Poppel M, Frank S, Wadsack C, Hauguel-de Mouzon S, Desoye G. Dysregulation of placental endothelial lipase in obese women with gestational diabetes mellitus. Diabetes 2011;60:2457-64.
93. Lindegaard ML, Olivecrona G, Christoffersen C, Kratky D, Hannibal J, Petersen BL, Zechner R, Damm P, Nielsen LB. Endothelial and lipoprotein lipases in human and mouse placenta. J Lipid Res 2005;46:2339-46.
94. Magnusson AL, Waterman IJ, Wennergren M, Jansson T, Powell TL. Triglyceride hydrolase activities and expression of fatty acid binding proteins in the human placenta in pregnancies complicated by intrauterine growth restriction and diabetes. J Clin Endocrinol Metab 2004;89:4607-14.
95. Abumrad N, Coburn C, Ibrahimi A. Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPm. Biochim Biophys Acta 1999;1441:4-13.
96. Larque E, Demmelmair H, Klingler M, De Jonge S, Bondy B, Koletzko B. Expression pattern of fatty acid transport protein-1 (FATP-1), FATP-4 and heart-fatty acid binding protein (H-FABP) genes in human term placenta. Early Hum Dev 2006;82:697-701.
97. Lewis RM, Hanson MA, Burdge GC. Umbilical venous-arterial plasma composition differences suggest differential incorporation of fatty acids in NEFA and cholesteryl ester pools. Br J Nutr 2011;106:463-7.
98. Haggarty P, Ashton J, Joynson M, Abramovich DR, Page K. Effect of maternal polyunsaturated fatty acid concentration on transport by the human placenta. Biol Neonate 1999;75:350-9.
99. Innis SM. Essential fatty acid transfer and fetal development. Placenta 2005;26:Suppl A:S70-5.
100. Gil-Sanchez A, Larque E, Demmelmair H, Acien MI, Faber FL, Parrilla JJ, Koletzko B. Maternal-fetal in vivo transfer of [13C] docosahexaenoic and other fatty acids across the human placenta 12 h after maternal oral intake. Am J Clin Nutr 2010;92:115-22.
101. Kazantzis M, Stahl A. Fatty acid transport proteins, implications in physiology and disease. Biochim Biophys Acta 2012;1821:852-7.
102. Duttaroy AK, Crozet D, Taylor J, Gordon MJ. Acyl-CoA thioesterase activity in human placental choriocarcinoma (BeWo), cells: effects of fatty acids. Prostaglandins Leukot Essent Fatty Acids 2003;68:43-8.
103. Pagan A, Prieto-Sanchez MT, Blanco-Carnero JE, Gil-Sanchez A, Parrilla JJ, Demmelmair H, Koletzko B, Larque E. Materno-fetal transfer of docosahexaenoic acid is impaired by gestational diabetes mellitus. Am J Physiol Endocrinol Metab 2013;305:E826-33.
104. Dancis J, Jansen V, Kayden HJ, Schneider H, Levitz M. Transfer across perfused human placenta. II. Free fatty acids. Pediatr Res 1973;7:192-7.
105. Bitsanis D, Ghebremeskel K, Moodley T, Crawford MA, Djahanbakhch O. Gestational diabetes mellitus enhances arachidonic and docosahexaenoic acids in placental phospholipids. Lipids 2006;41:341-6.
106. Kuhn DC, Crawford MA, Stuart MJ, Botti JJ, Demers LM. Alterations in transfer and lipid distribution of arachidonic acid in placentas of diabetic pregnancies. Diabetes 1990;39:914-8.
107. Desoye G, Shafrir E. Placental metabolism and its regulation in health and diabetes. Mol Aspects Med 1994;15:505-682.
108. Diamant YZ, Metzger BE, Freinkel N, Shafrir E. Placental lipid and glycogen content in human and experimental diabetes mellitus. Am J Obstet Gynecol 1982;144:5-11.
109. Jones CJ, Fox H. Ultrastructure of the normal human placenta. Electron Microsc Rev 1991;4:129-78.
110. Pathmaperuma AN, Mana P, Cheung SN, Kugathas K, Josiah A, Koina ME, Broomfield A, Delghingaro-Augusto V, Ellwood DA, Dahlstrom JE, Nolan CJ. Fatty acids alter glycerolipid metabolism and induce lipid droplet formation, syncytialisation and cytokine production in human trophoblasts with minimal glucose effect or interaction. Placenta 2010;31:230-9.
111. Elchalal U, Schaiff WT, Smith SD, Rimon E, Bildirici I, Nelson DM, Sadovsky Y. Insulin and fatty acids regulate the expression of the fat droplet-associated protein adipophilin in primary human trophoblasts. Am J Obstet Gynecol 2005;193:1716-23.
112. Scifres CM, Chen B, Nelson DM, Sadovsky Y. Fatty acid binding protein 4 regulates intracellular lipid accumulation in human trophoblasts. J Clin Endocrinol Metab 2011;96:E1083-91.
113. Hauguel S, Desmaizieres V, Challier JC. Glucose uptake, utilization, and transfer by the human placenta as functions of maternal glucose concentration. Pediatr Res 1986;20:269-73.
114. Rakheja D, Bennett MJ, Foster BM, Domiati-Saad R, Rogers BB. Evidence for fatty acid oxidation in human placenta, and the relationship of fatty acid oxidation enzyme activities with gestational age. Placenta 2002;23:447-50.
115. Shekhawat P, Bennett MJ, Sadovsky Y, Nelson DM, Rakheja D, Strauss AW. Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases. Am J Physiol Endocrinol Metab 2003;284:E1098-105.
116. Kuhn DC, Botti JJ, Cherouny PH, Demers LM. Eicosanoid production and transfer in the placenta of the diabetic pregnancy. Prostaglandins 1990;40:205-15.
117. Muskiet FA, Fokkema MR, Schaafsma A, Boersma ER, Crawford MA. Is docosahexaenoic acid (DHA) essential? Lessons from DHA status regulation, our ancient diet, epidemiology and randomized controlled trials. J Nutr 2004;134:183-6.
118. Le HD, Meisel JA, de Meijer VE, Gura KM, Puder M. The essentiality of arachidonic acid and docosahexaenoic acid. Prostaglandins Leukot Essent Fatty Acids 2009;81:165-70.
119. Herrera E. Lipid metabolism in pregnancy and its consequences in the fetus and newborn. Endocrine 2002;19:43-55.
120. Herrera E, Amusquivar E, Lopez-Soldado I, Ortega H. Maternal lipid metabolism and placental lipid transfer. Horm Res 2006;65:Suppl 3:59-64.
121. Matorras R, Ruiz JI, Mendoza R, Ruiz N, Sanjurjo P, Rodriguez-Escudero FJ. Fatty acid composition of fertilization-failed human oocytes. Hum Reprod 1998;13:2227-30.
122. Uauy R, Treen M, Hoffman DR. Essential fatty acid metabolism and requirements during development. Semin Perinatol 1989;13:118-30.
123. Koletzko B, Cetin I, Brenna JT, Perinatal Lipid Intake Working Group; Child Health Foundation; Diabetic Pregnancy Study Group; European Association of Perinatal Medicine; European Association of Perinatal Medicine; European Society for Clinical Nutrition and Metabolism; European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Committee on Nutrition; International Federation of Placenta Associations; International Society for the Study of Fatty Acida and Lipids.. Dietary fat intakes for pregnant and lactating women. Br J Nutr 2007;98:873-7.
124. Carlson SE, Werkman SH, Peeples JM, Cooke RJ, Tolley EA. Arachidonic acid status correlates with first year growth in preterm infants. Proc Natl Acad Sci USA 1993;90:1073-7.
125. Woltil HA, van Beusekom CM, Schaafsma A, Muskiet FA, Okken A. Long-chain polyunsaturated fatty acid status and early growth of low birth weight infants. Eur J Pediatr 1998;157:146-52.
126. Girard J, Ferre P, Pegorier JP, Duee PH. Adaptations of glucose and fatty acid metabolism during perinatal period and suckling-weaning transition. Physiol Rev 1992;72:507-62.
127. Oey NA, den Boer ME, Ruiter JP, Wanders RJ, Duran M, Waterham HR, Boer K, van der Post JA, Wijburg FA. High activity of fatty acid oxidation enzymes in human placenta: implications for fetal-maternal disease. J Inherit Metab Dis 2003;26:385-92.
128. Strauss AW. Surprising? Perhaps not. Long-chain fatty acid oxidation during human fetal development. Pediatr Res 2005;57:753-4.
129. Oey NA, den Boer ME, Wijburg FA, Vekemans M, Auge J, Steiner C, Wanders RJ, Waterham HR, Ruiter JP, Attie-Bitach T. Longchain fatty acid oxidation during early human development. Pediatr Res 2005;57:755-9.
130. Rinaldo P, Matern D, Bennett MJ. Fatty acid oxidation disorders. Annu Rev Physiol 2002;64:477-502.
131. Bennett MJ, Rinaldo P, Strauss AW. Inborn errors of mitochondrial fatty acid oxidation. Crit Rev Clin Lab Sci 2000;37:1-44.
132. Ibdah JA, Paul H, Zhao Y, Binford S, Salleng K, Cline M, Matern D, Bennett MJ, Rinaldo P, Strauss AW. Lack of mitochondrial trifunctional protein in mice causes neonatal hypoglycemia and sudden death. J Clin Invest 2001;107:1403-9.
133. Kurtz DM, Rinaldo P, Rhead WJ, Tian L, Millington DS, Vockley J, Hamm DA, Brix AE, Lindsey JR, Pinkert CA, O'Brien WE, Wood PA. Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation. Proc Natl Acad Sci USA 1998;95:15592-7.
134. Cox KB, Hamm DA, Millington DS, Matern D, Vockley J, Rinaldo P, Pinkert CA, Rhead WJ, Lindsey JR, Wood PA. Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse. Hum Mol Genet 2001;10:2069-77.
135. Kompare M, Rizzo WB. Mitochondrial fatty-acid oxidation disorders. Semin Pediatr Neurol 2008;15:140-9.
136. Hahn P, Novak M. Development of brown and white adipose tissue. Journal of lipid research 1975;16:79-91.
137. Van Aerde JE, Wilke MS, Feldman M, Clandinin MT. Accretion of lipid in the fetus and newborn, 4th ed. Philadelphia: Elsevier, Saunders, 2011.
138. Heim T. Energy and lipid requirements of the fetus and the preterm infant. J Pediatr Gastroenterol Nutr 1983;2:Suppl 1:S16-41.
139. Catalano PM, Kirwan JP. Maternal factors that determine neonatal size and body fat. Current diabetes reports 2001;1:71-7.
140. Desoye G, Hauguel-de Mouzon S, Shafrir E. The placenta in diabetic pregnancy: placental transfer of nutrients, 2nd ed. London: Informa Healthcare, 2003.
141. Villee CA, Loring JM. Alternative pathways of carbohydrate metabolism in foetal and adult tissues. Biochem J 1961;81:488-94.
142. Villee CA, Hagerman DD, Holmberg N, Lind J, Vilee DB. The effects of anoxia on the metabolism of human fetal tissues. Pediatrics 1958;22:953-71.
143. Dunlop M, Court JM. Lipogenesis in developing human adipose tissue. Early Hum Dev 1978;2:123-30.
144. Coltart TM. Effect on fetal liver lipids of 14 C glucose administered intravenously to the mother. J Obstet Gynaecol Br Commonw 1972;79:639-43.
145. Villee CA, Hagerman DD. Effect of oxygen deprivation on the metabolism of fetal and adult tissues. Am J Physiol 1958;194:457-64.
146. Yoshioka T, Roux JF. In vitro metabolism of palmitic acid in human fetal tissue. Pediatr Res 1972;6:675-81.
147. Volpe JJ, Kishimoto Y. Fatty acid synthetase of brain: development, influence of nutritional and hormonal factors and comparison with liver enzyme. J Neurochem 1972;19:737-53.
148. Ailhaud G, Grimaldi P, Negrel R. Cellular and molecular aspects of adipose tissue development. Annu Rev Nutr 1992;12:207-33.
149. Rosen ED, MacDougald OA. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 2006;7:885-96.
150. Poissonnet CM, Burdi AR, Bookstein FL. Growth and development of human adipose tissue during early gestation. Early Hum Dev 1983;8:1-11.
151. Feng B, Zhang T, Xu H. Human adipose dynamics and metabolic health. Ann N Y Acad Sci 2013;1281:160-77.
152. Ailhaud G, Hauner H. Development of white adipose tissue, 2nd ed. New York, N.Y.: Marcel Dekker, 2004.
153. Sjostrom L, William-Olsson T. Prospective studies on adipose tissue development in man. Int J Obes 1981;5:597-604.
154. Cristancho AG, Lazar MA. Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol 2011;12:722-34.
155. Tontonoz P, Spiegelman BM. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem 2008;77:289-312.
156. Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994;79:1147-56.
157. Weiss PA, Scholz HS, Haas J, Tamussino KF, Seissler J, Borkenstein MH. Long-term follow-up of infants of mothers with type 1 diabetes: evidence for hereditary and nonhereditary transmission of diabetes and precursors. Diabetes Care 2000;23:905-11.
158. Sewell MF, Huston-Presley L, Super DM, Catalano P. Increased neonatal fat mass, not lean body mass, is associated with maternal obesity. Am J Obstet Gynecol 2006;195:1100-3.
159. Hull HR, Dinger MK, Knehans AW, Thompson DM, Fields DA. Impact of maternal body mass index on neonate birthweight and body composition. Am J Obstet Gynecol 2008;198: 416 e1-6.
160. Estampador AC, Pomeroy J, Renstrom F, Nelson SM, Mogren I, Persson M, Sattar N, Domellof M, Franks PW. Infant body composition and adipokine concentrations in relation to maternal gestational weight gain. Diabetes Care 2014;37:1432-8.
161. Carlsen EM, Renault KM, Norgaard K, Nilas L, Jensen JE, Hyldstrup L, Michaelsen KF, Cortes D, Pryds O. Newborn regional body composition is influenced by maternal obesity, gestational weight gain and the birthweight standard score. Acta Paediatr 2014;103:939-45.
162. Streuling I, Beyerlein A, von Kries R. Can gestational weight gain be modified by increasing physical activity and diet counseling? A meta-analysis of interventional trials. Am J Clin Nutr 2010;92:678-87.
163. Tanentsapf I, Heitmann BL, Adegboye AR. Systematic review of clinical trials on dietary interventions to prevent excessive weight gain during pregnancy among normal weight, overweight and obese women. BMC Pregnancy Childbirth 2011;11:81.
164. Thangaratinam S, Rogozinska E, Jolly K, Glinkowski S, Roseboom T, Tomlinson JW, Kunz R, Mol BW, Coomarasamy A, Khan KS. Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence. Br Med J 2012;344:e2088.
165. Amri EZ, Ailhaud G, Grimaldi PA. Fatty acids as signal transducing molecules: involvement in the differentiation of preadipose to adipose cells. J Lipid Res 1994;35:930-7.
166. Xu HE, Lambert MH, Montana VG, Parks DJ, Blanchard SG, Brown PJ, Sternbach DD, Lehmann JM, Wisely GB, Willson TM, Kliewer SA, Milburn MV. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell 1999;3:397-403.
167. Ailhaud G, Massiera F, Weill P, Legrand P, Alessandri JM, Guesnet P. Temporal changes in dietary fats: role of n-6 polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity. Prog Lipid Res 2006;45:203-36.
168. Azain MJ. Role of fatty acids in adipocyte growth and development. J Anim Sci 2004;82:916-24.
169. Hauner H, Much D, Vollhardt C, Brunner S, Schmid D, Sedlmeier EM, Heimberg E, Schuster T, Zimmermann A, Schneider KT, Bader BL, Amann-Gassner U. Effect of reducing the n-6:n-3 long-chain PUFA ratio during pregnancy and lactation on infant adipose tissue growth within the first year of life: an open-label randomized controlled trial. Am J Clin Nutr 2012;95:383-94.
170. Hauner H, Brunner S, Amann-Gassner U. The role of dietary fatty acids for early human adipose tissue growth. Am J Clin Nutr 2013;98:549S-55S.
171. Catalano PM, Thomas A, Huston-Presley L, Amini SB. Increased fetal adiposity: a very sensitive marker of abnormal in utero development. Am J Obstet Gynecol 2003;189:1698-704.
172. Enzi G, Inelmen EM, Caretta F, Villani F, Zanardo V, DeBiasi F. Development of adipose tissue in newborns of gestationaldiabetic and insulin-dependent diabetic mothers. Diabetes 1980;29:100-4.
173. Enzi G, Inelmen EM, Caretta F, Rubaltelli F, Grella P, Baritussio A. Adipose tissue development "in utero". Relationships between some nutritional and hormonal factors and body fat mass enlargement in newborns. Diabetologia 1980;18:135-40.
174. Cortelazzi D, Corbetta S, Ronzoni S, Pelle F, Marconi A, Cozzi V, Cetin I, Cortelazzi R, Beck-Peccoz P, Spada, A. Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol (Oxf) 2007;66:447-53.
175. Christou H, Serdy S, Mantzoros CS. Leptin in relation to growth and developmental processes in the fetus. Semin Reprod Med 2002;20:123-30.
176. Mazaki-Tovi S, Kanety H, Pariente C, Hemi R, Schiff E, Sivan E. Cord blood adiponectin in large-for-gestational age newborns. Am J Obstet Gynecol 2005;193(3 Pt 2):1238-42.
177. Briana DD, Malamitsi-Puchner A. Reviews: adipocytokines in normal and complicated pregnancies. Reprod Sci 2009;16:921-37.
178. Briana DD, Malamitsi-Puchner A. Intrauterine growth restriction and adult disease: the role of adipocytokines. Eur J Endocrinol 2009;160:337-47.
179. Briana DD, Malamitsi-Puchner A. The role of adipocytokines in fetal growth. Ann N Y Acad Sci 2010;1205:82-7.
180. Smith AJ, Thompson BR, Sanders MA, Bernlohr DA. Interaction of the adipocyte fatty acid-binding protein with the hormonesensitive lipase: regulation by fatty acids and phosphorylation. J Biol Chem 2007;282:32424-32.
181. Okereke NC, Uvena-Celebrezze J, Hutson-Presley L, Amini SB, Catalano PM. The effect of gender and gestational diabetes mellitus on cord leptin concentration. Am J Obstet Gynecol 2002;187:798-803.
182. Gross GA, Solenberger T, Philpott T, Holcomb WL, Jr., Landt M. Plasma leptin concentrations in newborns of diabetic and nondiabetic mothers. Am J Perinatol 1998;15:243-7.
183. Lepercq J, Cauzac M, Lahlou N, Timsit J, Girard J, Auwerx J, Hauguel-de Mouzon S. Overexpression of placental leptin in diabetic pregnancy: a critical role for insulin. Diabetes 1998;47:847-50.
184. Maffei M, Volpe L, Di Cianni G, Bertacca A, Ferdeghini M, Murru S, Teti G, Casadidio I, Cecchetti P, Navalesi R, Benzi L. Plasma leptin levels in newborns from normal and diabetic mothers. Horm Metab Res 1998;30:575-80.
185. Marchini G, Fried G, Ostlund E, Hagenas L. Plasma leptin in infants: relations to birth weight and weight loss. Pediatrics 1998;101(3 Pt 1):429-32.
186. Wolf HJ, Ebenbichler CF, Huter O, Bodner J, Lechleitner M, Foger B, Patsch JR, Desoye G. Fetal leptin and insulin levels only correlate inlarge-for-gestational age infants. Eur J Endocrinol 2000;142:623-9.
187. Ategbo JM, Grissa O, Yessoufou A, Hichami A, Dramane KL, Moutairou K, Miled A, Grissa A, Jerbi M, Tabka Z, Khan NA. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab 2006;91:4137-43.
188. Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006;354:2552-63.
189. Choi SH, Kwak SH, Youn BS, Lim S, Park YJ, Lee H, Kim YB, Park KS, Jang HC. High plasma retinol binding protein-4 and low plasma adiponectin concentrations are associated with severity of glucose intolerance in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 2008;93:3142-8.
190. Corbetta S, Bulfamante G, Cortelazzi D, Barresi V, Cetin I, Mantovani G, Bondioni S, Beck-Peccoz P, Spada A. Adiponectin expression in human fetal tissues during mid-and late gestation. J Clin Endocrinol Metab 2005;90:2397-402.
191. Kadowaki K, Waguri M, Nakanishi I, Miyashita Y, Nakayama M, Suehara N, Funahashi T, Shimomura I, Fujita T. Adiponectin concentration in umbilical cord serum is positively associated with the weight ratio of fetus to placenta. J Clin Endocrinol Metab 2006;91:5090-4.
192. Romeo S, Yin W, Kozlitina J, Pennacchio LA, Boerwinkle E, Hobbs HH, Cohen JC. Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J Clin Invest 2009;119:70-9.
193. Koster A, Chao YB, Mosior M, Ford A, Gonzalez-DeWhitt PA, Hale JE, Li D, Qiu Y, Frase, CC, Yang DD, Heuer JG, Jaskunas SR, Eacho P. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology 2005;146:4943-50.
194. Ortega-Senovilla H, Schaefer-Graf U, Meitzner K, Abou-Dakn M, Herrera E. Decreased concentrations of the lipoprotein lipase inhibitor angiopoietin-like protein 4 and increased serum triacylglycerol are associated with increased neonatal fat mass in pregnant women with gestational diabetes mellitus. J Clin Endocrinol Metab 2013;98:3430-7.
195. Johnson HJ Jr, Simpson ER, Carr BR, MacDonald PC, Parker RC Jr. The levels of plasma cholesterol in the human fetus throughout gestation. Pediatr Res 1982;16:682-3.
196. Donega S, Oba J, Maranhao RC. [Concentration of serum lipids and apolipoprotein B in newborns]. Arq Bras Cardiol 2006;86:419-24.
197. Mott GE. Lipoprotein metabolism and nutritional programming in the fetus and neonate, 4th ed. Philadelphia: Elsevier Saunders, 2011.
198. Chow SN, Chen HY, Ouyang PC, Lee TY, Wei PY, Chen JS. Serum triglyceride levels in newborns and mothers at parturition. Int J Biol Res Pregnancy 1982;3:30-2.
199. Alvino G, Cozzi V, Radaelli T, Ortega H, Herrera E, Cetin I. Maternal and fetal fatty acid profile in normal and intrauterine growth restriction pregnancies with and without preeclampsia. Pediatr Res 2008;64:615-20.
200. Cai HJ, Xie CL, Chen Q, Chen XY, Chen YH. The relationship between hepatic low-density lipoprotein receptor activity and serum cholesterol level in the human fetus. Hepatology 1991;13:852-7.
201. Parker CR Jr, Carr BR, Simpson ER, MacDonald PC. Decline in the concentration of low-density lipoprotein-cholesterol in human fetal plasma near term. Metabolism 1983;32:919-23.
202. Davis PA, Forte TM, Nichols AV, Blum CB. Umbilical cord blood lipoproteins. Isolation and characterization of high density lipoproteins. Arteriosclerosis 1983;3:357-65.
203. Nichols AV, Blanche PJ, Genzel-Boroviczeny O, Forte TM, Gong EL. Apolipoprotein-specific populations in high density lipoproteins of human cord blood. Biochim Biophys Acta 1991;1085:306-4.
204. Winkler L, Schlag B, Goetze E. Concentration and composition of the lipoprotein classes in human umbilical cord serum. Clin Chim Acta 1977;76:187-91.
205. van Biervliet JP, Rosseneu M, Bury J, Caster H, Stul MS, Lamote R. Apolipoprotein and lipid composition of plasma lipoproteins in neonates during the first month of life. Pediatr Res 1986;20:324-8.
206. Averna MR, Barbagallo CM, Di Paola G, Labisi M, Pinna G, Marino G, Dimita U, Notarbartolo A. Lipids, lipoproteins and apolipoproteins AI, AII, B, CII, CIII and E in newborns. Biol Neonate 1991;60:187-92.
207. McConathy WJ, Lane DM. Studies on the apolipoproteins and lipoproteins of cord serum. Pediatr Res 1980;14:757-61.
208. Parker CR Jr, Fortunato SJ, Carr BR, Owen J, Hankins GD, Hauth JC. Apolipoprotein A-1 in umbilical cord blood of newborn infants: relation to gestational age and high-density lipoprotein cholesterol. Pediatr Res 1988;23:348-51.
209. Blum CB, Davis PA, Forte TM. Elevated levels of apolipoprotein E in the high density lipoproteins of human cord blood plasma. J Lipid Res 1985;26:755-60.
210. Augsten M, Hackl H, Ebner B, Chemelli A, Glatter O, Marsche G, Lang U, Desoye G, Wadsack C. Fetal HDL/apoE: a novel regulator of gene expression in human placental endothelial cells. Physiol Genomics 2011;43:1255-62.
211. Packard CJ, McKinney L, Carr K, Shepherd J. Cholesterol feeding increases low density lipoprotein synthesis. J Clin Invest 1983;72:45-51.
212. Amr S, Chowdhry P, Hamosh P, Hamosh M. Low levels of apolipoprotein A1 are not contributors to the low lecithin-cholesterol acyl transferase activity in premature newborn infants. Pediatr Res 1988;24:191-3.
213. Lacko AG, Rutenberg HL, Soloff LA. On the rate of cholesterol esterification in cord blood serum. Lipids 1972;7:426-9.
214. Dolphin PJ, Breckenridge WC, Dolphin MA, Tan MH. The lipoproteins of human umbilical cord blood apolipoprotein and lipid levels. Atherosclerosis 1984;51:109-22.
215. Fordyce MK, Duncan R, Chao R, Christakis M, Hsia SL, Robertson E, Kafatos A, Christakis G. Cord blood serum in newborns of diabetic mothers. J Chronic Dis 1983;36:263-8.
216. Kilby MD, Neary RH, Mackness MI, Durrington PN. Fetal and maternal lipoprotein metabolism in human pregnancy complicated by type I diabetes mellitus. J Clin Endocrinol Metab 1998;83:1736-41.
217. Sreckovic I, Birner-Gruenberger R, Besenboeck C, Miljkovic M, Stojakovic T, Scharnagl H, Marsche G, Lang U, Kotur-Stevuljevic J, Jelic-Ivanovic Z, Desoye G, Wadsack C. Gestational diabetes mellitus modulates neonatal high-density lipoprotein composition and its functional heterogeneity. Biochim Biophys Acta 2014;1841:1619-27.
218. Higgins M, Mc Auliffe F. A review of maternal and fetal growth factors in diabetic pregnancy. Curr Diabetes Rev 2010;6:116-25.
219. Chex N, Scholl TO. Glucose, foetal growth and pregnancy. In: Pertry CJ, editor. Gestational diabetes: origins, complications and treatment. Boca Raton: CRC Press, 2014:3-32.
220. Simeonova-Krstevska S, Krstevska B, Velkoska-Nakova V, Hadji Lega M, Samardjiski I, Serafimoski V, Livrinova V, Todorovska I, Sima A. Effect of lipid parameters on foetal growth in gestational diabetes mellitus pregnancies. Prilozi 2014;35:131-6.
221. Kitajima M, Oka S, Yasuhi I, Fukuda M, Rii Y, Ishimaru T. Maternal serum triglyceride at 24-32 weeks' gestation and newborn weight in nondiabetic women with positive diabetic screens. Obstet Gynecol 2001;97(5 Pt 1):776-80.
222. Oken E, Gillman MW. Fetal origins of obesity. Obes Res 2003;11:496-506.
223. Catalano PM, Farrell K, Thomas A, Huston-Presley L, Mencin P, de Mouzon SH, Amini SB. Perinatal risk factors for childhood obesity and metabolic dysregulation. Am J Clin Nutr 2009; 90:1303-13.